Literature DB >> 13641436

The sensitivity of staphylococci and other wound bacteria to erythromycin, oleandomycin, and spiramycin.

E J LOWBURY, L HURST.   

Abstract

Entities:  

Keywords:  ANTIBIOTICS/effects; ERYTHROMYCIN/effects; MICROCOCCUS PYOGENES/effect of drugs on

Mesh：

Substances：

Year:  1959        PMID： 13641436      PMCID： PMC479882          DOI： 10.1136/jcp.12.2.163

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN： 0021-9746            Impact factor:   3.411


× No keyword cloud information.
  7 in total

1.  Spiramycin; clinical and laboratory studies.

Authors:  D G HUDSON; G M YOSHIHARA; W M KIRBY
Journal:  AMA Arch Intern Med       Date:  1956-01

2.  The erythromycin group of antibiotics.

Authors:  L P GARROD
Journal:  Br Med J       Date:  1957-07-13

3.  Chemotherapy for Staphylococcus aureus; combined use of novobiocin and erythromycin and other methods in the treatment of burns.

Authors:  E J LOWBURY
Journal:  Lancet       Date:  1957-08-17       Impact factor: 79.321

4.  Development of resistance and cross-resistance in vitro to erythromycin, carbomycin, spiramycin, oleandomycin and streptogramin.

Authors:  M FINLAND; W F JONES; R L NICHOLS
Journal:  Proc Soc Exp Biol Med       Date:  1956-11

5.  Bacteriophage typing of Staphylococcus aureus.

Authors:  R E O WILLIAMS; J E RIPPON
Journal:  J Hyg (Lond)       Date:  1952-09

6.  Chemotherapy for staphylococcus aureus in burns.

Authors:  E J L LOWBURY; E TOPLEY
Journal:  Lancet       Date:  1952-05-24       Impact factor: 79.321

7.  Laboratory studies of oleandomycin (matromycin).

Authors:  J E GERACI; G M NEEDHAM
Journal:  Antibiotic Med Clin Ther (New York)       Date:  1956-10
  7 in total
  22 in total

1.  High rate of tetracycline resistance in Streptococcus pyogenes in Iran: an epidemiological study.

Authors:  A Jasir; A Tanna; A Noorani; A Mirsalehian; A Efstratiou; C Schalen
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

2.  Evolution and global dissemination of macrolide-resistant group A streptococci.

Authors:  D Ashley Robinson; Joyce A Sutcliffe; Wezenet Tewodros; Anand Manoharan; Debra E Bessen
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

3.  Phenotypes and genotypes of erythromycin-resistant Streptococcus pyogenes strains isolated from invasive and non-invasive infections from Mexico and the USA during 1999-2010.

Authors:  Alberto Villaseñor-Sierra; Eva Katahira; Abril N Jaramillo-Valdivia; María de los Angeles Barajas-García; Amy Bryant; Rayo Morfín-Otero; Francisco Márquez-Díaz; Juan Carlos Tinoco; José Sánchez-Corona; Dennis L Stevens
Journal:  Int J Infect Dis       Date:  2012-01-02       Impact factor: 3.623

4.  Resistance of group A beta-hemolytic streptococci to lincomycin and erythromycin.

Authors:  J M Dixon; A E Lipinski
Journal:  Antimicrob Agents Chemother       Date:  1972-04       Impact factor: 5.191

5.  Characterization of a plasmid determining resistance to erythromycin, lincomycin, and vernamycin Balpha in a strain Streptococcus pyogenes.

Authors:  D B Clewell; A E Franke
Journal:  Antimicrob Agents Chemother       Date:  1974-05       Impact factor: 5.191

6.  Group A Streptococcus resistant to erythromycin and lincomycin.

Authors:  J M Dixon
Journal:  Can Med Assoc J       Date:  1968-12-07       Impact factor: 8.262

7.  Group A streptococci resistant to lincomycin.

Authors:  J Kohn; J H Hewitt; C A Fraser
Journal:  Br Med J       Date:  1968-03-16

8.  Antibiotic susceptibility of group A streptococci: a 6-year follow-up study.

Authors:  C Betriu; A Sanchez; M Gomez; A Cruceyra; J J Picazo
Journal:  Antimicrob Agents Chemother       Date:  1993-08       Impact factor: 5.191

9.  Inducible and constitutive resistance to macrolide antibiotics and lincomycin in clinically isolated strains of Streptococcus pyogenes.

Authors:  S L Hyder; M M Streitfeld
Journal:  Antimicrob Agents Chemother       Date:  1973-09       Impact factor: 5.191

10.  Pharmacoepidemiological analysis of provincial differences between consumption of macrolides and rates of erythromycin resistance among Streptococcus pyogenes isolates in Spain.

Authors:  C García-Rey; L Aguilar; F Baquero; J Casal; J E Martín
Journal:  J Clin Microbiol       Date:  2002-08       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.